Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
J Physiol Pharmacol ; 62(4): 395-402, 2011 Aug.
Article in English | MEDLINE | ID: mdl-22100840

ABSTRACT

Pharmacological activation of the glucagon-like peptide-1 (GLP-1) receptor and inhibition of the cannabinoid CB1 receptor were found to reduce food intake and body weight in humans and animals. Since earlier studies revealed that endocannabinoids may interact with other neurotransmitters to affect feeding behavior, we have examined whether a stable GLP-1 agonist, exendin-4 and a CB1 receptor antagonist, AM 251, may reciprocally enhance their inhibitory effects on food consumption in the rat. Additionally, we have tested whether the blockade of the GLP-1 receptor by exendin (9-39) modifies AM 251-dependent effects on energy balance. In a dose-response study, male Wistar rats were injected intraperitoneally with either 1.5-6.0 µg/kg exendin-4, 0.5-2 mg/kg AM 251, 80-320 µg/kg exendin (9-39) or their vehicle and the daily food and water intake as well as body weight changes were monitored two days before and two days after the injection. Exendin-4 at a dose of 3.0 and 6.0 µg/kg and AM 251 at a dose 2 mg/kg decreased significantly 24-hour food intake and body weight. Therefore, in the next study, the effects of lower doses of exendin-4 (1.5 µg/kg) and AM 251 (1.0 mg/kg) administered alone or together on food consumption were compared. As opposed to being injected alone, the co-administration of the two resulted in a marked decrease in both daily food intake and body weight. Exendin (9-39) did not modify the suppressory effect of the highest AM 251 dose on food consumption. Apparently, the effect of AM 251 on the appetite is not mediated by GLP-1. The concomitant stimulation of GLP-1 receptor and blockade of CB1 receptor, however, may act synergistically to inhibit appetite in the rat.


Subject(s)
Body Weight/drug effects , Eating/drug effects , Receptor, Cannabinoid, CB1/antagonists & inhibitors , Receptors, Glucagon/agonists , Animals , Appetite Depressants/administration & dosage , Appetite Depressants/pharmacology , Dose-Response Relationship, Drug , Drug Synergism , Energy Metabolism/drug effects , Exenatide , Glucagon-Like Peptide-1 Receptor , Male , Peptides/administration & dosage , Peptides/pharmacology , Piperidines/administration & dosage , Piperidines/pharmacology , Pyrazoles/administration & dosage , Pyrazoles/pharmacology , Rats , Rats, Wistar , Venoms/administration & dosage , Venoms/pharmacology
2.
Acta Biochim Pol ; 47(2): 293-300, 2000.
Article in English | MEDLINE | ID: mdl-11051194

ABSTRACT

Normal human T lymphocytes growing in culture undergo replicative senescence. Previously, we have shown that in our conditions polyclonal T cells cease proliferation after about three weeks (Radziszewska et al., 1999, Cell Biol. Int. 23, 97-103). Now we present results of a more detailed analysis of in vitro growth as well as phenotypic changes of T cells. Cell cycle analysis showed that about 20% of cells were in the S phase until the 17th day of culture (young cells). The highest number of mitotic cells (phase G2/M; 10%) was observed during the first week of culture. All not dividing senescent cells were stopped in the G1 phase (after the 30th day of culture). The sub-G1 fraction which represents apoptotic cells did not exceed 8% during the whole period until the 30th day of culture. During in vitro T-cell growth, a rather rapid selection to CD3+ CD8+ cells occurs. In the presenescent (between the 17th and 30th day) and senescent populations the majority of cells (above 90%) were CD8 positive. We also have checked the expression of alpha-chain interleukin-2 (IL-2) receptor (CD25). In young and presenescent cells about one third of cells was CD25 positive, but only 15% in the pool of senescent cells. Immunoblotting analysis of p16 protein recognized previously as a marker of senescent T cells, showed its highest and transient expression in presenescent cells. A critical review of the polyclonal T cell replicative senescence model is presented.


Subject(s)
Apoptosis/physiology , Cellular Senescence/physiology , T-Lymphocytes/cytology , T-Lymphocytes/physiology , Adult , Antigens, CD/analysis , Cell Division , Cells, Cultured , Cyclin-Dependent Kinase Inhibitor p16/analysis , Humans , Immunophenotyping , Receptors, Interleukin-2/analysis , T-Lymphocytes/immunology
3.
Acta Biochim Pol ; 47(2): 339-47, 2000.
Article in English | MEDLINE | ID: mdl-11051198

ABSTRACT

UVC-induced apoptotic symptoms such as morphological changes, DNA fragmentation, Bcl-2 and Bax protein expression were examined in primary splenocyte cultures from young (3 months) and old (24 months) rats. The activities of AP-1 and CRE transcription factors in UVC-irradiated splenocytes were also assessed. At 24 h after UVC irradiation 40% of cells derived from young rats were found to be apoptotic, which was twice as much as in splenocytes from old rats. Apoptosis in cells from old rats did not give typical symptoms like a "DNA ladder" and Bcl-2 protein downregulation, in contrast to splenocytes from young rats. No AP-1 transcription factor activity was found in UVC-irradiated splenocytes from old animals and only a trace activity in splenocytes from young animals. This indicates that, UVC-induced apoptosis in rat splenocytes is practically AP-1 independent and that cells from old rats are less sensitive to UVC irradiation than splenocytes from young rats.


Subject(s)
Apoptosis/radiation effects , Cellular Senescence/radiation effects , Lymphocytes/cytology , Lymphocytes/physiology , Spleen/growth & development , Ultraviolet Rays , Aging , Animals , Cells, Cultured , Cyclic AMP Response Element-Binding Protein/metabolism , DNA Fragmentation , Lymphocytes/radiation effects , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins c-bcl-2/analysis , Rats , Rats, Wistar , Transcription Factor AP-1/metabolism , bcl-2-Associated X Protein
4.
Nutr Cancer ; 38(1): 131-8, 2000.
Article in English | MEDLINE | ID: mdl-11341039

ABSTRACT

Curcumin, a major active component of turmeric, has been recognized as an anticarcinogenic agent because of its propensity to induce apoptosis in vivo and in vitro. Previously, we showed that curcumin protects cells against oligonucleosomal DNA fragmentation and induces a novel apoptosis-like pathway in Jurkat cells (Piwocka et al. Exp Cell Res 249, 299-307, 1999). Here, we have studied the ability of curcumin to induce cell death in other human and rodent transformed as well as normal cells. Normal cells were quiescent or stimulated to proliferate. We showed that 50 microM pigment is able to induce cell death in all studied cells, but cell death symptoms varied for different cells. All the cells died as assessed by the TdT-mediated UTP nick end labeling method or trypan blue exclusion test. No one type of cells showed oligonucleosomal DNA fragmentation (DNA "ladder") due to curcumin action, although in HL-60 cells, we were able to observe sub-G1 formation and caspase-3 activation. Together, these data showed that curcumin induces cell death in all tested cells that can be classified as apoptosis-like, and only in HL-60 cells can it be recognized as classical apoptosis.


Subject(s)
Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Curcumin/pharmacology , Lymphocytes/drug effects , Adult , Animals , Caspase 3 , Caspases/metabolism , Cell Division/drug effects , Cell Line, Transformed , Cells, Cultured , DNA Fragmentation , Flow Cytometry , Humans , In Situ Nick-End Labeling , Lymphocytes/cytology , Rats , Time Factors , Tumor Cells, Cultured
5.
Cell Biol Int ; 23(2): 97-103, 1999.
Article in English | MEDLINE | ID: mdl-10561118

ABSTRACT

We compared the in vitro propensity of human IL-2-dependent lymphocytes (young proliferating and senescent non-proliferating), and resting peripheral blood lymphocytes (PBLs) to undergo UVC-induced apoptosis. The activities of AP-1 (activator protein-1), CRE (cAMP response element) and OCT-1 (octamer-1) transcription factors in all lymphocytes were also assessed. At 24 h after UVC treatment, half of young proliferating T lymphocytes and about a quarter of PBLs and senescent non-proliferating cells were apoptotic, as shown by flow cytometry. However, only in young lymphocytes were both typical DNA 'ladder' and Bcl-2 downregulation evident. The AP-1 transcription factor was activated by UVC in IL-2-dependent young and senescent, but not resting lymphocytes. Taken together, the data show different propensities of resting, proliferating and senescent human lymphocytes to undergo UVC-induced apoptosis and AP-1 activation.


Subject(s)
Apoptosis/radiation effects , Interleukin-2/pharmacology , T-Lymphocytes/cytology , T-Lymphocytes/radiation effects , Adult , Cell Division , Cellular Senescence , Cyclic AMP Response Element-Binding Protein/metabolism , DNA Fragmentation/radiation effects , DNA-Binding Proteins/metabolism , Host Cell Factor C1 , Humans , In Vitro Techniques , Lymphocyte Activation , Octamer Transcription Factor-1 , Proto-Oncogene Proteins/metabolism , Proto-Oncogene Proteins c-bcl-2/metabolism , Recombinant Proteins/immunology , T-Lymphocytes/metabolism , Transcription Factor AP-1/metabolism , Transcription Factors/metabolism , Ultraviolet Rays , bcl-2-Associated X Protein
6.
Biochem Pharmacol ; 56(8): 961-5, 1998 Oct 15.
Article in English | MEDLINE | ID: mdl-9776306

ABSTRACT

Curcumin (CUR) is a natural yellow dye with antioxidant and scavenging properties present in Curcuma species. It is widely used as an anti-inflammatory, anti-mutagenic and chemopreventive agent. In addition to its inhibitory effect on proliferation, CUR has recently been shown to block dexamethasone-induced programmed cell death (apoptosis) of rat thymocytes. Because cellular thiols seem to play a role in redox regulation of apoptosis, the mechanism of the anti-apoptotic effect of CUR was studied by examining the levels of glutathione and acid-soluble sulfhydryl groups. CUR was shown to prevent the glutathione loss occurring in dexamethasone-treated thymocytes, enhancing intracellular glutathione content at 8 hr to 192% of that of nontreated cells. A 60% increase in acid-soluble sulfhydryl groups was also observed. In the presence of L-buthionine S,R-sulfoximine (BSO, an inhibitor of glutathione synthesis), intracellular glutathione content of thymocytes treated with dexamethasone and CUR fell to 31% and that of the acid-soluble sulfhydryl groups to 23% of control after 8 hr. Unexpectedly, the electrophoretic and flow cytometric studies of DNA fragmentation demonstrated that apoptosis did not occur even after 20 hr of incubation with buthionine S,R-sulfoximine and dexamethasone, while control thymocytes and the cells treated only with buthionine S,R-sulfoximine showed DNA fragmentation at a level corresponding to spontaneous apoptosis. These results show that CUR treatment elevated the concentrations of glutathione and nonprotein sulfhydryl groups, thus preventing their decrease in apoptotic thymocytes. Coadministration of L-buthionine S,R-sulfoximine and CUR did not affect the anti-apoptotic effect of CUR suggesting a glutathione-independent mechanism of cell protection.


Subject(s)
Antioxidants/pharmacology , Apoptosis/drug effects , Curcumin/pharmacology , Free Radical Scavengers/pharmacology , Glutathione/metabolism , Thymus Gland/drug effects , Animals , Coloring Agents , DNA Fragmentation , Dexamethasone/antagonists & inhibitors , Rats , Thymus Gland/cytology
7.
Jt Comm J Qual Improv ; 24(5): 232-9, 1998 May.
Article in English | MEDLINE | ID: mdl-9626616

ABSTRACT

THE POLISH HEALTH CARE SYSTEM: The health care system in Poland is based on a model typical of east-central European countries, with features such as state-owned health care organizations, centralized management and administration, and primacy of access to care over quality. Poorly planned and uncoordinated reforms have been undertaken to transfer some of the authority for health service management to local governments. PRIMARY HEALTH CARE IN POLAND: The reform of the health care system entails substitution of family physician-based for medical specialist-based primary care. Newly trained family physicians, as the first to start private surgery clinics financed from public sources, are the forerunners of the comprehensive reform and property structure transformation. MAKING THE TRANSITION FROM QUALITY ASSURANCE TO QUALITY IMPROVEMENT: Since the early 1990s, more and more organizations, individuals, and professional groups have begun to perceive health care regulations and other external control mechanisms as ineffective. Attempts have been made to replace periodic, restrictive activities with systematic continuous quality improvement efforts. Systems of voluntary accreditation are being developed and fostered. Groups have started meeting to develop medical practice guidelines and conduct peer review. Concern about quality of health care services is now reflected in the Polish legislation for the first time, as well as in numerous local and nationwide projects and publications. CONCLUSION: Despite some successes, the pioneers of quality improvement (QI) still have a long way to go. Continuation of educational activities and creation of a system of motivation for the development, of QI in primary care should be prioritized and encouraged.


Subject(s)
Primary Health Care/standards , State Medicine/standards , Total Quality Management/standards , Health Care Reform , Humans , Poland , Quality Assurance, Health Care
8.
Biochem Biophys Res Commun ; 244(3): 912-6, 1998 Mar 27.
Article in English | MEDLINE | ID: mdl-9535767

ABSTRACT

Human fibroblast cultures, which have a finite replicative lifespan in vitro, are the most widely used model for the study of senescence at the cellular level. An inverse relationship between replicative capability and donor age has been reported in human fibroblast strains. We studied the growth capacity of fibroblast primary cultures derived from people whose lifespan was as closer as possible to the expected maximum human lifespan, i.e. people over one hundred. Our data suggest that outgrowth of fibroblasts from biopsies, growth kinetics at different population doubling levels, capability to respond to a classical mitogenic stimulus (such as 20% serum) and a variety of growth factors, were remarkably similar in fibroblasts from centenarians and young controls. On the whole, our data challenge the tenet of a simple and strict relationship between in vivo aging and in vitro proliferative capability of human fibroblasts, at least at the individual level.


Subject(s)
Aging/physiology , Fibroblasts/cytology , Growth Substances/pharmacology , Skin/cytology , Adolescent , Adult , Aged , Aged, 80 and over , Cell Cycle/drug effects , Cellular Senescence , Child , Female , Fibroblasts/drug effects , Humans , Male , Middle Aged
9.
Biochem Pharmacol ; 54(8): 899-907, 1997 Oct 15.
Article in English | MEDLINE | ID: mdl-9354590

ABSTRACT

Curcumin (diferuoylmethane), the yellow pigment in the rhizome of tumeric (Curcuma longa), an ingredient of curry spice, is known to exhibit a variety of pharmacological effects including antitumor, antiinflammatory, and antiinfectious activities. Although its precise mode of action remains elusive, curcumin has been shown to suppress the activity of the AP-1 transcription factor in cells stimulated to proliferate. In this study, we observed that curcumin (50 microM) inhibited proliferation of rat thymocytes stimulated with concanavalin A (Con A) as well as that of human Jurkat lymphoblastoid cells in the logarithmic growth phase. The pigment also inhibited apoptosis in dexamethasone-treated rat thymocytes and in UV-irradiated Jurkat cells as judged by DNA ladder formation, cellular morphological changes, and flow cytometry analysis. The inhibition of apoptosis by curcumin in rat thymocytes was accompanied by partial suppression of AP-1 activity. Complete suppression of AP-1 activity was observed in Con A-treated, proliferating thymocytes. The capacity of curcumin to inhibit both cell growth and death strongly implies that these two biological processes share a common pathway at some point and that curcumin affects a common step, presumably involving a modulation of the AP-1 transcription factor.


Subject(s)
Apoptosis/drug effects , Cell Division/drug effects , Curcumin/pharmacology , Growth Inhibitors/pharmacology , Lymphocyte Activation/drug effects , T-Lymphocytes/drug effects , Animals , Concanavalin A/pharmacology , DNA/metabolism , DNA-Binding Proteins/metabolism , Dexamethasone/pharmacology , Glucocorticoids/pharmacology , Humans , Rats , Rats, Wistar , Transcription Factor AP-1/metabolism , Tumor Cells, Cultured
10.
Biochem Biophys Res Commun ; 226(2): 517-23, 1996 Sep 13.
Article in English | MEDLINE | ID: mdl-8806666

ABSTRACT

In vitro replicative senescence is characterized by an irreversible growth arrest due to the inability of the cell to induce some key regulators of cell cycle progression, such as c-fos and AP-1, in response to mitogenic stimuli. In vitro replicative senescence and in vivo aging have been assumed to be two related phenomena, likely controlled by overlapping or interacting genes. As a corollary, fibroblasts from centenarians, which have undergone a long process of senescence in vivo should have very limited proliferative capability. On the contrary, in a previous work we found that fibroblasts from centenarians exhibited the same capacity to respond to different mitogenic stimuli as fibroblasts from young donors. Here we provide evidences that the well preserved proliferative response is likely due to the fact that some pivotal regulators- c-fos, c-jun and AP-1-are still fully inducible, despite a long process of in vivo senescence. Our data therefore suggest that in vivo and in vitro aging are separate phenomena whose possible relationships, if any, have to be ascertained very carefully.


Subject(s)
Aging/genetics , Genes, fos , Genes, jun , Skin/metabolism , Transcription Factor AP-1/metabolism , Adolescent , Adult , Aged , Aged, 80 and over , Base Sequence , Child , Cyclic AMP Response Element-Binding Protein/metabolism , DNA/metabolism , DNA Primers , Fibroblasts/metabolism , Humans , Middle Aged , Molecular Sequence Data , Protein Binding , Skin/cytology
11.
Przegl Lek ; 52(10): 499-503, 1995.
Article in Polish | MEDLINE | ID: mdl-8834841

ABSTRACT

The studies carried out on young piglets were to demonstrate that experimentally increased pulmonary flow resulted in collagen hyperproduction in the pulmonary tissue. In 14 piglets a modified Blalock-Taussig anastomosis was performed, 9 animals constituted the controls. The survivors included 9 experimental and 8 control piglets. In direct lung biopsies the biochemical collagen content was assessed, whereas histopathology confirmed the development of vascular lesions characteristic for pulmonary hypertension. A significant increase of collagen level in the pulmonary tissue was demonstrated in experimental animals. Determinations were also made of serum and urine hydroxyproline values. A significant increase was observed in serum and urine hydroxyproline values in experimental animals in comparison to the controls when determinations were made 7 days to 3 months after the anastomosis had been performed (p < 0.01). The authors showed that an increase of pulmonary flow in piglets results in collagen metabolism disturbances which are seen both in an increased collagen level in the tissue and in increased serum and hydroxyproline levels.


Subject(s)
Collagen/metabolism , Lung/metabolism , Pulmonary Circulation/physiology , Anastomosis, Surgical , Animals , Biopsy , Disease Models, Animal , Female , Heart Defects, Congenital/physiopathology , Hydroxyproline/blood , Hydroxyproline/urine , Lung/pathology , Male , Swine
12.
Biochem Biophys Res Commun ; 197(2): 709-15, 1993 Dec 15.
Article in English | MEDLINE | ID: mdl-8267607

ABSTRACT

The onset of apoptosis is generally thought to require the induction of a novel genetic program. Accordingly, we studied the kinetic of DNA-binding activity of several transcription factors in rat thymocytes undergoing apoptosis induced by dexamethasone (DEX) or heat shock (HS) treatment. Here we report that: 1) early activation of AP-1 occurred in both models of apoptosis, even if the intensity of activation and AP-1 complex composition were different and much less evident in HS-treated thymocytes; 2) early NFkB DNA-binding activity was also observed in both types of apoptosis; 3) downregulation of other transcription factors, such as OCT-1 and CREB, with high constitutive activity, was recorded in both models of apoptosis. The fact that some TFs are up-regulated while others are down-regulated suggests that apoptosis is the result of a complex combination of positive and negative signals regulating gene expression.


Subject(s)
Apoptosis/physiology , DNA-Binding Proteins/metabolism , Dexamethasone/pharmacology , T-Lymphocytes/cytology , T-Lymphocytes/metabolism , Transcription Factors/metabolism , Animals , Apoptosis/drug effects , Cyclic AMP Response Element-Binding Protein/metabolism , DNA-Binding Proteins/isolation & purification , Electrophoresis, Polyacrylamide Gel , Host Cell Factor C1 , Hot Temperature , NF-kappa B/metabolism , Octamer Transcription Factor-1 , Proto-Oncogene Proteins c-jun/metabolism , Proto-Oncogenes , Rats , Rats, Sprague-Dawley , T-Lymphocytes/drug effects , Transcription Factors/isolation & purification
13.
Acta Biochim Pol ; 40(2): 269-72, 1993.
Article in English | MEDLINE | ID: mdl-8212965

ABSTRACT

The study of human disorders known as premature aging syndromes may provide insight into the mechanisms of cellular senescence. The main feature of cellular senescence in vitro is cessation of cell proliferation. Down syndrome (DS) and neuronal ceroid-lypofuscinosis (NCL) are clinically characterized by the premature onset of numerous features normally associated with human aging. Phytohemagglutinin stimulated lymphocytes derived from DS subjects showed a statistically significant diminished proliferation capacity in comparison with lymphocytes derived from NCL and healthy individuals. We demonstrated, by applying the electrophoretic mobility shift assay, slightly impaired AP-1 DNA binding activity in NCL lymphocytes and strong in DS ones. Our results showed that the same molecular mechanisms of proliferation cessation could exist in fibroblasts characterized by replicative senescence and in lymphocytes derived from individuals with premature aging syndromes (Down).


Subject(s)
DNA/blood , Lymphocytes/physiology , Progeria/blood , Proto-Oncogene Proteins c-jun/blood , Adolescent , Adult , Child , Down Syndrome/blood , Electrophoresis , Humans , Lymphocyte Activation/drug effects , Lymphocytes/drug effects , Lymphocytes/metabolism , Neuronal Ceroid-Lipofuscinoses/blood , Phytohemagglutinins/pharmacology , Stimulation, Chemical , Thymidine/metabolism , Tritium
14.
FEBS Lett ; 312(2-3): 179-82, 1992 Nov 09.
Article in English | MEDLINE | ID: mdl-1426249

ABSTRACT

The main feature of cellular senescence is cessation of cell proliferation. Protooncogene c-fos, which is required for the cell to enter into DNA synthesis, is repressed in senescent fibroblasts. Diminished expression of c-fos and impaired formation of AP-1, which is a complex of c-Fos and c-Jun proteins acting as a transcription factor, was found in lymphocytes derived from old (> 18 months) mice and stimulated with Con A. There were no differences in c-jun expression and formation of other transcription factors (AP-2 and AP-3) between lymphocytes isolated from old and young mice.


Subject(s)
Cellular Senescence/physiology , DNA/metabolism , Lymphocytes/cytology , Proto-Oncogene Proteins c-jun/metabolism , Animals , Base Sequence , Cells, Cultured , Concanavalin A/pharmacology , Lymphocytes/metabolism , Mice , Molecular Sequence Data , Protein Binding , Proto-Oncogene Proteins c-fos/genetics , Proto-Oncogene Proteins c-jun/genetics , RNA, Messenger/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...